Members of the U.S. House of Representatives on both sides of the aisle say they'll work with the president to bring down drug costs. The bipartisan push could cause the pharmaceutical industry to lose the pricing power it relies upon to drive earnings growth, some analysts warn.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,